208 related articles for article (PubMed ID: 21879392)
1. Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin.
Cai Z; Song X; Sun F; Yang Z; Hou S; Liu Z
AAPS PharmSciTech; 2011 Dec; 12(4):1102-9. PubMed ID: 21879392
[TBL] [Abstract][Full Text] [Related]
2. [Brain targeting of gastrodin nasal in situ gel].
Cai Z; Hou SX; Yang ZX; Song XR; Chen QH; Li YB; Zhao BB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):438-40. PubMed ID: 18575335
[TBL] [Abstract][Full Text] [Related]
3. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
Galgatte UC; Kumbhar AB; Chaudhari PD
Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
[TBL] [Abstract][Full Text] [Related]
4. [Study on drug release of gastrodin ion-activated nasal in situ gel in vitro].
Cai Z; Hou SX; Song XR; Yang ZX; Zheng Y; Zhao BB
Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(7):760-2. PubMed ID: 18589772
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and stability investigation of gastrodin dispersible tablets].
Xi YW; Huang GH; Li LJ
Zhong Yao Cai; 2006 Sep; 29(9):970-3. PubMed ID: 17212058
[TBL] [Abstract][Full Text] [Related]
6. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration.
Salunke SR; Patil SB
Int J Biol Macromol; 2016 Jun; 87():41-7. PubMed ID: 26899173
[TBL] [Abstract][Full Text] [Related]
7. In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits.
Mahajan HS; Gattani S
Drug Deliv; 2010 Jan; 17(1):19-27. PubMed ID: 19958151
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
9. Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy.
Cao SL; Zhang QZ; Jiang XG
Acta Pharmacol Sin; 2007 Apr; 28(4):584-90. PubMed ID: 17376300
[TBL] [Abstract][Full Text] [Related]
10. Development of mucoadhesive sprayable gellan gum fluid gels.
Mahdi MH; Conway BR; Smith AM
Int J Pharm; 2015 Jul; 488(1-2):12-9. PubMed ID: 25863119
[TBL] [Abstract][Full Text] [Related]
11. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate.
Cao SL; Ren XW; Zhang QZ; Chen E; Xu F; Chen J; Liu LC; Jiang XG
Int J Pharm; 2009 Jan; 365(1-2):109-15. PubMed ID: 18822361
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
[TBL] [Abstract][Full Text] [Related]
13. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
14. Nasal delivery of analgesic ketorolac tromethamine thermo- and ion-sensitive in situ hydrogels.
Li X; Du L; Chen X; Ge P; Wang Y; Fu Y; Sun H; Jiang Q; Jin Y
Int J Pharm; 2015 Jul; 489(1-2):252-60. PubMed ID: 25957699
[TBL] [Abstract][Full Text] [Related]
15. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine.
Qian S; Wong YC; Zuo Z
Int J Pharm; 2014 Jul; 468(1-2):272-82. PubMed ID: 24709220
[TBL] [Abstract][Full Text] [Related]
16. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine.
Chen Y; Liu Y; Xie J; Zheng Q; Yue P; Chen L; Hu P; Yang M
Int J Nanomedicine; 2020; 15():10435-10451. PubMed ID: 33380794
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic comparative study of tetramethylpyrazine and ferulic acid and their compatibility with different concentration of gastrodin and gastrodigenin on blood-stasis migraine model by blood-brain microdialysis method.
Mi Y; Guo S; Cheng H; Liu M; Wei P; Wang M; Mao Y; Ke G
J Pharm Biomed Anal; 2020 Jan; 177():112885. PubMed ID: 31563759
[TBL] [Abstract][Full Text] [Related]
18. Performance and toxicity of different absorption enhancers used in the preparation of Poloxamer thermosensitive in situ gels for ketamine nasal administration.
Xia Y; Li L; Huang X; Wang Z; Zhang H; Gao J; Du Y; Chen W; Zheng A
Drug Dev Ind Pharm; 2020 May; 46(5):697-705. PubMed ID: 32293206
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of dual action intranasal formulation intended for postoperative/cancer associated therapies.
El-Setouhy DA; Ahmed S; Badawi AA; El-Nabarawi MA; Sallam N
Eur J Pharm Sci; 2015 Aug; 76():48-56. PubMed ID: 25917526
[TBL] [Abstract][Full Text] [Related]
20. Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups.
Krauland AH; Leitner VM; Bernkop-Schnürch A
J Pharm Sci; 2003 Jun; 92(6):1234-41. PubMed ID: 12761812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
